Federation des caisses Desjardins du Quebec’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,236	Closed	-$4.97K	–	2417
2023 Q1	$4.97K	Hold	38,236	–	–	﹤0.01%	1913
2022 Q4	$6.27K	Sell	38,236 -98,675	-72%	-$41.3K	﹤0.01%	1988
2022 Q3	$89K	Sell	136,911 -500	-0.4%	-$737	﹤0.01%	1353
2022 Q2	$334K	Hold	137,411	–	–	﹤0.01%	912
2022 Q1	$555K	Sell	137,411 -6,990	-5%	-$38.3K	0.01%	801
2021 Q4	$1.16M	Buy	144,401 +9,543	+7%	+$112K	0.01%	616
2021 Q3	$2.6M	Buy	134,858 +36,890	+38%	+$645K	0.03%	394
2021 Q2	$1.35M	Buy	97,968 +81,996	+513%	+$971K	0.01%	612
2021 Q1	$144K	Buy	+15,972	New	+$117K	﹤0.01%	1221

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PLXP Position: Q2 2023 in Review

Federation des caisses Desjardins du Quebec sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 38,236 shares — an estimated $4.97K sold.

Federation des caisses Desjardins du Quebec first reported a position in PLXP in Q1 2021 and held it in 9 quarters. The position peaked at $2.6M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Federation des caisses Desjardins du Quebec reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 38,236 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $4.97K.
Federation des caisses Desjardins du Quebec first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Federation des caisses Desjardins du Quebec's PLx Pharma Inc. Common Stock position peaked at $2.6M in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2023, filed 15 Aug 2024.